Carolyn Rucci
General Counsel at AKEBIA THERAPEUTICS, INC.
Profile
Carolyn M.
Rucci is currently the Senior Vice President-Legal & General Counsel at Akebia Therapeutics, Inc. Prior to her current position, she served as the Vice President & Deputy General Counsel at AMAG Pharmaceuticals, Inc. from 2016 to 2021.
She also worked as a Principal at Wilmer Cutler Pickering Hale & Dorr LLP.
Ms. Rucci holds a graduate degree from Boston University School of Law and an undergraduate degree from Trinity College.
Carolyn Rucci active positions
Companies | Position | Start |
---|---|---|
AKEBIA THERAPEUTICS, INC. | General Counsel | 2020-12-31 |
Former positions of Carolyn Rucci
Companies | Position | End |
---|---|---|
AMAG PHARMACEUTICALS, INC. | General Counsel | 2020-12-31 |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of Carolyn Rucci
Boston University School of Law | Graduate Degree |
Trinity College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AKEBIA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Carolyn Rucci